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Abstract: Background: Although the prevalence of uremic pruritus has
decreased compared to the past, the problem still remains as a matter of health
and a major challenge of research in medical ﬁeld, and has no effective
treatment at present. This study aimed to investigate the effect of increasing
blood ﬂow rate on severity of uremic pruritus in hemodialysis patients in Iran.
Methods: This clinical trial was performed on 60 hemodialysis patients that
referred to hospitals afﬁliated to Tehran University of Medical Sciences and
these patients were selected through the convenience method and were
treated for four weeks. They were divided into two groups of experimental
and control as random allocation block, and studied for 4 weeks. Information
on pruritus severity was collected using a researcher-made questionnaire in
three steps of before intervention and two and four weeks after start of
intervention. The rate of blood ﬂow was increased in the ﬁrst two weeks and
the second two weeks by 25 and 50 rounds per minute (rpm) compared to
the mean rate of blood ﬂow of hemodialysis device in the last two sessions
before intervention. Data were analyzed using the tests ManneWhitney,
Fisher, and t-test.
Results: Analysis of data from 50 persons in both groups who completed the
study revealed a signiﬁcant difference between the groups in the severity of
pruritus between the two sessions of hemodialysis (pruritus at home) at the end
of the ﬁrst two weeks of the intervention (<0.05) and the number of cases of
pruritus (<0.05) at the end of the study.
Conclusions: Increasing blood ﬂow for hemodialysis machine can induce
signiﬁcant statistical and clinical reduction in the severity and the frequency of
pruritus in hemodialysis patients and can be help to be improve the quality of life
of these persons by increased the blood ﬂow rate.
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ruritus is an unpleasant sensation that stimulates the
desire to scratch. It is an important symptom of skinPdiseases and a frequent manifestation of systemic
diseases. Uremia is the leading cause of pruritus among all
systemic diseases.1 The complication affects 50-90% of
peritoneal dialysis and hemodialysis patients and its symp-
toms range from mild, local to severe, generalized.2 The rate
of pruritus in hemodialysis patients was 52% in 20113 and
45.2% in 2015.4 Uremic pruritus is often uncontrollable and
leads to many problems in hemodialysis patients,1 so that
the quality of life is drastically reduced and less attention
has been paid at the bedside to the psychosocial impact of
skin dryness and uremic pruritus.5 Increased severity of
pruritus is associated with frequency of scratching and sleep
disturbance,2 with negative effect on sleep and mood,6
resulting in decreased quality of life of these patients2 and
since pruritus occurs mostly at night6 it causes sleep
disruption is 70% in patients. Prognosis of patients with
severe pruritus is signiﬁcantly worse than other patients,7 so
that it can increase the risk of mortality and morbidity by
17% and this relationship between mortality and pruritus
can also be attributed to poor quality of sleep.8
Pathophysiological mechanism of pruritus associated
with chronic renal failure still remains unknown.9 Some
references have been attributed the intensity of uremic
pruritus to the level of calcium, phosphorus, and urea
nitrogen before dialysis.7 Many pharmacological and
non-pharmacological therapies have been used for the
treatment of uremic pruritus including antihistamines, mild
soaps, local anesthesia, cholestyramine, ultraviolet light,
acupuncture, parathyroidectomy, gamma rays, oral acti-
vated charcoal, and increased dialysis adequacy.10,11 Some
studies such as Heliotherapy that after treatment of patients
with severe pruritus (grade 4), the intensity of pruritus has
decreased from grade 4 to grade 3 in 41.66% and it has
decreased from grade 4 to grade 2 in 8.33%12 and capsa-
icin 3% ointment that reduced average of pruritus scoreJOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
iences from ClinicalKey.com by Elsevier on September 08, 2019.
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INCREASING BLOOD FLOW RATE AND UREMIC PRURITUSfrom 15.9 to 2.5 during the 4 weeks, it has been used in the
treatment of uremic pruritus.13 Although the prevalence of
uremic pruritus has decreased compared to the past, the
problem still remains as a matter of health9 and a major
challenge of research in medical ﬁeld,14 and has no
effective treatment at present.2
One indicator in study of therapeutic effects of he-
modialysis can be dialysis adequacy that cause of
increased or decreased of symptoms15 and to increase
dialysis adequacy can be used to increase blood ﬂow
rate.16,17 Damage kidney function leads to accumulation
of different materials of pruritus-causing and accumula-
tion of waste products such as urea and phosphorus is
one of the reasons of pruritus in hemodialysis patients11;
also according to studies increase blood ﬂow rate is
effective in removing phosphorus18 and increasing
adequacy of dialysis,16,17 now the question is whether
increased blood ﬂow rate will change the severity of
pruritus or not. According to literature review no study
was performed in this regard therefore this study aimed
to investigate the effect of increasing blood ﬂow rate on
severity of uremic pruritus in hemodialysis patients in
Iran.METHODS
This study is a single-blind clinical trial (the interviewer
did not know the patients grouping into intervention and
control) performed after approval in 2011 by Tehran
University of Medical Sciences. In this study due to lack of
sufﬁcient sample in a center and sampling is performed by
Sampling Access Method. In this way, patients at one
center were selected as the intervention group and those in
two other centers as controls group. The selected hospitals
were similar in terms of treatment type and equipment.
Initially the number of samples was 30 subjects in each
group which declined to 25 due to sample drop. It is
noteworthy that the subjects were matched in terms of age
and gender. The type of ﬁlter and type of anti-pruritus
medications (Renagel and Hydroxyzine) were the same
during the study. The data were collected in this study
through self-report during interviews, observation of the
ﬁles and recording the information in questionnaire and the
mean changes in body weight were measured with a
digital scale (Seca marking) and blood pressure with a
sphygmomanometer (Welch allyn marking). The data
were collected in this study through self-report during
interviews which contains four parts of testimonial,
inclusion and exclusion criteria, demographic data, and
recording the information about machine (round of pump)
and questions related to disease. Questions about the
disease were included hemodialysis history, cause ofJOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
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anti-pruritus drug, pruritus immediately before, during,
immediately after and between two sessions of hemodi-
alysis (at home), the number of cases of pruritus in a day
pruritus without scratching, mild (1-3), moderate (4-6),
and severe (7 and more), and the site of pruritus (pruritus
in a local member and more than one member of general).
It is noteworthy that the positive pruritus in the each
mentioned times, the patient responds to questions related
to the severity of pruritus that was divided into three parts
of mild (pruritus without scratching), moderate (scratching
without scrape), and severe (scratching with scrape).
Inclusion criteria were included hemodialysis for at least
six months, hemodialysis duration three times a week for
4 h, pruritus (mild, moderate, and severe), absence of
severe heart disease, and exclusion criteria were blood
pressure less than 100/60 mmHg, hospitalization due to
acute problem, death, skin disease that cause pruritus,
active hepatobiliary disease. Bicarbonate dialysate,
hemodialysis machine (Fresenius 4008B), heparin, sets,
and ﬁlter used for all patients in the study were the same.
At ﬁrst average of pump velocity was considered two
sessions before the intervention and then 25 rpm in the ﬁrst
two weeks (6 session) and 50 rpm in the second two weeks
(the second six session) compared to the mean pump
velocity in two sessions. The intervention was performed
as twelve 4-h sessions for four weeks. In the ﬁrst 15 min of
each session, the pump velocity was low and then was
gradually increased to the desired velocity. Drugs were
recorded that patients used for pruritus and were asked to
patients that are not change these drugs. During the study,
Patients’ blood pressure and weight (for the 4-h hemodi-
alysis) were measured and recorded by the investigator
before initiation of dialysis. It is noteworthy that in all
sessions, the researcher and two research assistants atten-
ded in the hospitals and the conditions of patients’
hemodialysis were stable. Information questionnaire was
collected verbally in three stages, before the intervention,
at the end of the second week and at the end of the fourth
week. The tool’s validity was determined using experts’
comments (10 persons) and content validity and reliability
through the Pearson correlation coefﬁcient (90%). To
analyze the data based on normal Kolmogorov-smirnov of
nonparametric tests was used Exact ﬁsher’s test (age,
education, marital status, and cause of kidney failure),
independent t-test (duration of hemodialysis, duration of
pruritus, the frequency of pruritus), Chi-square (gender,
site of pruritus, and use of anti-pruritus drug and Eprex),
ManneWhitney (severity pruritus), and ANOVA with
repeated measures (frequency of pruritus before and
after in each group) and software of SPSS-18. Values are
signiﬁcant at P < 0.05.VOL 110, NO 3, JUNE 2018 271
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INCREASING BLOOD FLOW RATE AND UREMIC PRURITUSThe study is approved by the ethical committee of
Yasuj University of Medical Sciences. The study was
performed according to Helsinki principals in ethics. All of
the participants signed a written constant.
RESULTS
During the study 72% and 52% of patients in the experi-
mental and control group consumed medications such as
antihistamines, renagel, hydroxyzine, Erythropoietin and
Gabapentin respectively (P > 0.05).
The results related to demographic and clinical char-
acteristic have been illustrated in Table 1.
As shown in Table 2, the two groups had no statisti-
cally signiﬁcant difference regarding the severity in all
four stages before intervention, while the severity of
pruritus between the two sessions of hemodialysis
became signiﬁcant after two weeks and four weeks using
the ManneWhitney test (P  0.05).
The two groups had no statistically signiﬁcant differ-
ences in terms of pruritus frequency per day before and
two weeks after the intervention, while the difference
became signiﬁcant after four weeks (P  0.05, indepen-
dent t-test) (Table 3).
Analysis of variance with repeated measures showed a
signiﬁcant difference between before and after the inter-
vention in the experimental group in terms of pruritus
frequency (P  0.05). No signiﬁcant difference in
improvement the number of cases of pruritus during
treatment between two groups and the number of cases of
pruritus signiﬁcantly decreased each time. There was sig-
niﬁcant effect between type of group and pruritus
improvement during the time and the implication is that
achieved improvement at any point of time compared toTable 1. Table of demographic and clinical characteristic.
Experimental
Age (40-59)*** 52
Male* 68
Under high school diploma** 58
Married** 100
History of hemodialysis (1-5 years)*** 44
Cause of disease (hypertension)** 48
History of pruritus less than one year*** 52
Two groups was not signiﬁcant demographic and clinical characteri
*Chi-square test.
**Exact ﬁsher’s test.
***Independent T-test.
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have been illustrated in Table 4.
DISCUSSION
The results of this study showed that increased blood ﬂow
rate causes a change of pruritus terms from generalized to
locally, reduced the severity of pruritus between the two
sessions of hemodialysis (pruritus at home) and the num-
ber of cases of pruritus in hemodialysis patients but it is
not effect of pruritus immediately before, during, imme-
diately after hemodialysis. Two weeks after the interven-
tion, the severity of pruritus reduced immediately before,
during, immediately after in all three steps and between
two sessions of hemodialysis after four weeks of inter-
vention in the experimental group, but in the control
group, pruritus decreased in the ﬁrst and last steps and
remained unchanged in the second steps and increased in
third steps.
The study of Borzoo et al showed that increasing blood
ﬂow rate is effective in removal of phosphorus and
increasing of hemodialysis adequacy.16,18 Another study
titled the impact of increased blood ﬂow rate on dialysis
adequacy in hemodialysis patients with low Kt/v by Kim
et al. This study showed that blood ﬂow rate increased by
15e20% can increase dialysis adequacy compared to
before.19 In addition, a study by Shahdadi et al showed
that an appropriate increase in blood ﬂow rate can
improved dialysis adequacy.20 Also a study by Gotzwiller
approved the impact of increased round of pump from
200 to 250 on removal of phosphorous.17 In another study
by Aliasgharpou et al increasing blood ﬂow rate improves
sleep disturbance Induced By Uremic Pruritus in hemo-
dialysis patients.21 Therefore, since some references haveControl P-value Statistic
44 >0.05 0.00
86 >0.05 c2 ¼ 0.00, df ¼ 1
52 >0.05 0.55
92 >0.05 0.49
44 >0.05 0.34
52 >0.05 0.77
72 >0.05 1.36
stic (P  0.05).
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Table 2. Table of severity of uremic pruritus difference between the two groups.
Pruritus severity
Immediately
before hemodialysis During hemodialysis
Immediately after
hemodialysis
Between 2 session
hemodialysis
Low Medium Severe
Without
pruritus Low Medium Severe
Without
pruritus Low Medium Severe
Without
pruritus Low Medium Severe
Without
pruritus
Before
intervention
Control 0 8 4 88 4 40 0 56 0 12 0 88 0 72 28 0
Experimental 0 12 20 68 8 36 4 52 0 16 16 68 0 52 44 4
P-value
ManneWhitney
>./05 >./05 >./05 >./05
Statistic 1/54 ./27 1/51 1/51
2 weeks
after
Control 0 16 4 76 4 44 0 52 0 12 0 88 1 76 4 8
Experimental 0 8 8 84 12 28 0 60 8 20 0 72 0 88 12 0
P-value
ManneWhitney
>./05 >./05 >./05 <./05
Statistic ./83 ./26 1/47 1/97
4 weeks
after
Control 4 16 4 76 4 44 0 52 0 20 0 80 0 80 16 4
Experimental 8 4 0 88 24 0 0 76 16 0 0 84 52 24 0 24
P-value
ManneWhitney
>./05 >./05 >./05 <./05
Statistic ./94 ./97 ./7 2/23
The two groups showed no statistically signiﬁcant difference in terms of pruritus severity in all four stages before intervention, but after two and four weeks after start of
intervention, pruritus severity between two hemodialysis sessions became signiﬁcant (ManneWhitney. P ¼ 0.04 and P ¼ 0.02).
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Table 3. Table of differences between the two groups in the number of cases of pruritus per day.
Experimental group Control group
P-value StatisticMild Medium Severe Mild Medium Severe
Before intervention 24 28 48 24 44 32 >0.05 1/88
2 weeks after 40 24 32 12 76 12 >0.05 ./42
4 weeks after 56 16 12 8 72 20 <0.05 3/74
The two groups had no statistically signiﬁcant difference in the number of cases of pruritus before intervention. Two weeks after the
intervention the difference was not signiﬁcant either. However, after four weeks it became signiﬁcant (P  0.05, independent T-test).
INCREASING BLOOD FLOW RATE AND UREMIC PRURITUSmentioned that cause of pruritus in hemodialysis patients is
increased of waste resources include phosphor, calcium,
and urea nitrogen.7,11 The results of the mentioned studies
support the ﬁndings of this study. It is noteworthy that
results of these studies are the result of increased blood
ﬂow rate in a session but the present study was conducted
in 12 dialysis sessions.
Zuker et al stated that resting of patients worsens pru-
ritus6 and insigniﬁcance of pruritus during and immedi-
ately after hemodialysis can be justiﬁed to this fact,
because patients are at rest during hemodialysis. Insigni-
ﬁcance of pruritus immediately before hemodialysis may
also be due to accumulation of waste products generated
between two hemodialysis sessions. In this study, the
frequency of pruritus at the end of intervention was
reduced in the experimental group (the result could be dueTable 4. Table of Local Pruritus (the site of itching).
Time Local of pruritus Experimen
Before intervention Local 32
General 68
Without pruritus 0
2 weeks after Local 52
General 44
Without pruritus 4
4 weeks after Local 56
General 28
Without pruritus 0
Two groups was not signiﬁcant in site of pruritus before intervention (
intervention (<0.05 Chi-square test).
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other studies and the reasons of reducing the severity of
pruritus that are mentioned in the previous paragraph). The
mentioned studies have measured the impact of increased
blood ﬂow rate on some electrolytes and dialysis ade-
quacy. However, the present study assessed the effect of
intervention on pruritus as one of the complications of
renal failure and hence the accumulation of waste prod-
ucts. Therefore, it seems that increased blood ﬂow rate
improves pruritus of patients through removal of electro-
lytes and waste materials and increases hemodialysis
adequacy.
The results of this study show that increasing blood
ﬂow rate of hemodialysis machine is causing reduce the
severity and number of cases of pruritus and limiting it
from general to locally.Group
P-value Statistictal Control
20 >0.05 c2 ¼ 4.50, df ¼ 1
80
0
8 <0.05 1.91
c2 ¼ 1.91, df ¼ 292
0
8 <0.05 c2 ¼ 18/87, df ¼ 2
92
0
P  0.05) but it was signiﬁcant two and four weeks after the
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INCREASING BLOOD FLOW RATE AND UREMIC PRURITUSLimitations and suggestions
Pruritus is a mental phenomenon making difﬁcult its
measurement and it may be inﬂuenced by many variables
such as air temperature, skin moisture, and nutrition and
results of this study is resulting thesis and there was a time
limitation. Therefore, it is suggested that a study can be
done with the same title and with simultaneous control of
nutrition and environmental factors or with more time.
Implication fore practice
This result can be help to be improve the quality of life of
these persons by increased the blood ﬂow rate in the
patient’s tolerance and reduced the severity of pruritus, and
this intervention can be used to help patients due to the fact
that it can be done without additional spending time and
manpower.
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